'I expect India to be concerned about US pharma tariffs': Rubio on Trump's 200% storm

US Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise significantly after August 1, 2026, impacting imports. The issue was not raised during his discussions with India's External Affairs Minister S Jaishankar. However, the matter might have been discussed with other US administration members. Both nations also underscored concluding an interim bilateral trade arrangement.